Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 259.0 | 61 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 274.0 | 87 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 271.5 | 74 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 282.0 | 74 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 284.0 | 67 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 310.0 | 66 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 345.0 | 74 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | GM-CSF | 376.5 | 66 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 299.0 | 59 | |
N2759 | TNF-a | 100 | ng/mL | 3 | GM-CSF | 311.0 | 58 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 351.0 | 67 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | GM-CSF | 376.0 | 69 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | GM-CSF | 338.5 | 78 | |
N2586 | TNF-a | 100 | ng/mL | 3 | GM-CSF | 342.0 | 85 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GM-CSF | 206.0 | 69 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | GM-CSF | 190.0 | 64 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GM-CSF | 206.0 | 74 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | GM-CSF | 198.0 | 71 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GM-CSF | 199.5 | 72 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | GM-CSF | 194.0 | 68 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | GM-CSF | 205.5 | 90 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | GM-CSF | 201.5 | 58 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | GM-CSF | 209.0 | 66 | ||||
RA1869 | 3 | GM-CSF | 210.0 | 65 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | GM-CSF | 201.0 | 70 |